Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Reksa Dana Pinnacle Core High Dividend ETF (XPDV)

UBC Medical Indonesia Tbk.Trading
Reksa Dana Pinnacle Core High Dividend ETFTrading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Reksa Dana Pinnacle Core High Dividend ETF: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Reksa Dana Pinnacle Core High Dividend ETF diperdagangkan di Rp587 (kapitalisasi pasar 760,5 jt, volume 24 jam 1 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 758,3× kapitalisasi pasar Reksa Dana Pinnacle Core High Dividend ETF, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 1 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSXPDV
Kapitalisasi Pasar
576,7 M760,5 jt
Volume
3,48 jt1 rb
Lot
34,82 rb10
Perputaran
522,79 jt587 rb
Harga Rata-rata
150,13587
Nilai Transaksi
522,79 jt587 rb
Harga Ekuilibrium Indikatif
148
Volume Ekuilibrium Indikatif
350

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Reksa Dana Pinnacle Core High Dividend ETF

Selengkapnya di halaman XPDV